Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ReLyfe Brands was a U.S. CBD consumer wellness brand focused on hemp-derived cannabidiol softgel capsules. The business appears to have operated as a branded product company rather than a drug developer, with commercial offerings that included THC-free CBD gel capsules sold in multiple package sizes. In 2019, NewLeaf Brands signed a definitive agreement to acquire ReLyfe, and subsequent disclosures listed ReLyfe as a wholly owned subsidiary alongside other CBD brands. In 2021, ReLyfe Brands was included among the U.S. cannabis assets transferred out of Mydecine into ALT House Cannabis Inc. As a result, ReLyfe is best characterized as an acquired cannabinoid wellness brand, not a biotech or pharmaceutical R&D company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ReLyfe Brands.